Clinical Physiology of Circulation

ISSN 1814-6910 (Print)
ISSN 2410-9134 (Online)

 

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Issue's catalogue ➤ КФК. 2023; 20 (4): 321-410 ➤ Хроническая тромбоэмболическая легочная гипертензия: влияние длительности заболевания и параметров гемодинамики на прогноз легочной тромбэндартерэктомии

Chronic thromboembolic pulmonary hypertension: the influence of disease duration and hemodynamic parameters on the prognosis of pulmonary thromboendarterectomy

Authors: Sabitov A.A.1, Chernogrivov I.E.1, Shmalts A.A.1 2, Gorbachevsky S.V. 1 2

Company:
1 Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation
2 Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2023-20-4-325-336

UDC: 616.149-008.341.1-005.755

Link: Clinical Physiology of Blood Circulaiton. 2023; 4 (20): 325-336

Quote as: Sabitov A.A., Chernogrivov I.E., Shmalts A.A., Gorbachevsky S.V. Chronic thromboembolic pulmonary hypertension: the influence of disease duration and hemodynamic parameters on the prognosis of pulmonary thromboendarterectomy. Clinical Physiology of Circulation. 2023; 20 (4): 325–36 (in Russ.). DOI: 10.24022/1814-6910-2023-20-4-325-336

Keywords:  pulmonary hypertension chronic thromboembolic pulmonary hypertension thromboendarterectomy balloon pulmonary angioplasty

Received / Accepted:  06.11.2023 / 26.11.2023

Download
Full text:  

Abstract

In this review article, all the main stages of the chronic thromboembolic pulmonary hypertension (CTEPH) development, modern diagnostic methods, and treatment are covered. The importance of evaluating the feasibility of performing pulmonary thromboendarterectomy (PTE) in an expert center is emphasized, which is a radical treatment method involving the removal of post-thrombotic material from the branches of the pulmonary artery. In cases where surgery is not feasible for patients with inoperable CTEPH, a transcatheter treatment method is proposed in the form of sequential balloon pulmonary angioplasty and specific medical therapy. The article provides a detailed description of modern criteria for selecting patients, defining indications and contraindications for PTE. Special attention is given in the publication to the possible effects of the duration of CTEPH history on indicators of pulmonary circulation hemodynamics, hospital mortality rate, and frequency of perioperative complications.

References

  1. Чазова И.Е., Мартынюк Т.В. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (II часть). Терапевтический архив. 2016; 88 (10): 63–73. DOI: 10.17116/terarkh201688663-73
  2. Чазова И.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Акчурин Р.С., Аншелес А.А. и др. Евразийские рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (2020). Евразийский кардиологический журнал. 2021; 1: 6–43. DOI: 10.38109/2225-1685-2021-1-6-43
  3. Galie N., Humbert M., Vachiery J.L., Simon G., Irene L., Adam T. et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension 2015. The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Heart J. 2016; 37: 67–119. DOI: 10.1093/eurheartj/ehv317
  4. Валиева З.С., Мартынюк Т.В., Наконечников С.Н., Чазова И.Е. Характеристика пациентов с хронической тромбоэмболической легочной гипертензией по данным Российского национального регистра. Терапевтический архив. 2021; 93 (9): 1058–65. DOI: 10.26442/00403660.2021.09.201037
  5. Hoeper M.M., Humbert M., Souza R., Idrees M., Steven M.K., Karen S.H. et al. A global view of pulmonary hypertension. Lancet Respir. Med. 2016; 4: 306–22. DOI: 10.1016/S2213-2600(15)00543-3
  6. Lang I.M., Dorfmüller P., Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann. Am. Thorac Soc. 2016; 13 (Suppl. 3): 215–21. DOI: 10.1513/AnnalsATS.201509-620AS
  7. Wartski M., Collignon M.A. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou heparin standard: evaluation dans l'embolie pulmonaire study. J. Nucl. Med. 2000; 41: 1043–8.
  8. Klok F.A., van Kralingen K.W., van Dijk A.P., Fenna H.H., Hubert W.V., Menno V.H. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010; 95: 970–5. DOI: 10.3324/haematol.2009.018960
  9. Pengo V., Lensing W.A., Prins M.H., Marchiori A., Davidson B.L. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N. Engl. J. Med. 2004; 350: 2257–64. DOI: 10.1056/NEJMoa032274
  10. Guérin L., Couturaud F., Parent F., Revel M.P., Gillaizeau F., Planquette B. et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb. Haemost. 2014; 112: 598–605. DOI: 10.1160/TH13-07-0538
  11. Simonneau G., Hoeper M.M. Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2017; 49 (2): 1602522. DOI: 10.1183/13993003.02522-2016
  12. Gall H., Hoeper M.M., Richter M.J., Cacheris W., Hinzmann B., Mayer E. et al. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur. Respir. Rev. 2017; 26: 160121. DOI: 10.1183/16000617.0121-2016
  13. Simonneau G., Torbicki A., Dorfmüller P., Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017; 26: 160112. DOI: 10.1183/16000617.0112-2016
  14. Madani M.M., Auger W.R., Pretorius V., Sakakibara N., Kerr K.M., Kim N.H. et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann. Thorac. Surg. 2012; 94 (1): 97–103. DOI: 10.1016/j.athoracsur.2012.04.004
  15. Mershin K.V., Akchurin R.S. Chronic thromboembolic pulmonary hypertension. In: Chazova I.E., Martynyuk T.V. (Eds). Pulmonary hypertension. Moscow; 2015: 563–606 (in Russ.).
  16. Bonderman D., Wilkens H., Wakounig S., Schäfers H.J., Jansa P., Lindner J. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33: 325–31. DOI: 10.1183/09031936.00087608
  17. Suntharalingam J., Goldsmith K., van Marion V., Long L., Treacy C.M., Dudbridge F. et al. Fibrinogen AThr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2008; 31: 736-41. DOI: 10.1183/09031936.00055107
  18. Marsh J.J. Chiles P.G., Liang Ni-Cheng, Morris T.A. Chronic thromboembolic pulmonary hypertensionassociated dysfibrinogenemias exhibit disorganized fibrin structure. Thromb. Res. 2013; 132: 729–34. DOI: 10.1016/j.thromres.2013.09.024
  19. Morris T.A., Marsh J.J., Chiles P.G., Auger W.R., Fedullo P.F., Woods V.L. et al. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am. J. Respir. Crit. Care Med. 2006; 173: 1270–5. DOI: 10.1164/rccm.200506-916OC
  20. Чернявский А.М., Едемский А.Г., Чернявский М.А., Караськов А.М. Хроническая тромбоэмболическая легочная гипертензия. В кн.: Авдеев С.Н. (ред.) Легочная гипертензия. 2-е изд. М.: ГЭОТАР-Медиа; 2019: 365–418.
  21. Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 2001; 345: 1465–72. DOI: 10.1056/NEJMra010902
  22. Чазова И.Е., Мартынюк Т.В. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (I часть). Терапевтический архив. 2016; 88 (9): 90–101. DOI: 10.17116/terarkh201688990-101
  23. Delcroix M., Lang I., Pepke-Zaba J., Jansa P., D'Armini A.M., Snijder R. et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation. 2016; 133: 859-71. DOI: 10.1161/CIRCULATIONAHA.115.016522
  24. Kim N.H., Delcroix M., Jais X., Madani M.M., Matsubara H., Mayeret E. et al. Chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019; 53: 1801915. DOI: 10.1183/13993003.01915-2018
  25. Савельев В.С., Яблоков Е.Г., Кириенко А.И. Тромбоэмболия легочных артерий. М.: Медицина; 1979: 264. Saveliev V.S., Yablokov E.G., Kirienko A.I. Pulmonary embolism. Moscow; 1979: 264 (in Russ.).
  26. Wagenvoort С.A. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest. 1980; 77: 614–25. DOI: 10.1378/chest.77.5.614
  27. Матюшенко А.А. Хроническая постэмболическая легочная гипертензия. В кн.: Савельев В.С. (ред.) 50 лекций по хирургии. М.: Медиа Медика; 2003: 99–105.
  28. Rich S., Levitsky S., Brundage В.Н. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann. Intern. Med. 1988; 108 (5): 425–54. DOI: 10.7326/0003-4819-108-3-425
  29. Kelly S., Zongye C., van der Velde N., van Duin R., Lam E., van der Velden J. et al. Cardiac remodelling in a swine model of chronicthromboembolic pulmonary hypertension: comparison of right vs. left ventricle. J. Physiol. 2019; 597 (17): 4465–80. DOI: 10.1113/JP277896
  30. Grifoni S., Olivotto I., Cecheini P., Pieralli F., Camaiti A., Santoro G. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101: 2817–22. DOI: 10.1161/01.cir.101.24.2817
  31. Banks D.A., Pretorius G.V., Kerr K.M., Manecke G.R. Pulmonary endarterectomy: Part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin. Cardiothorac. Vasc. Anesth. 2014; 18 (4): 319–30. DOI: 10.1177/1089253214536621
  32. Korsholm K., Andersen A., Mellemkjаеr S., Niclsen D.V., Klaaborg K.E. et al. Results from more than 20-years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark. Eur. J. Cardiothorac. Surg. 2017; 52 (4): 704–9. DOI: 10.1093/ejcts/ezx182
  33. Блинова Е.В., Сахнова Т.А., Мартынюк Т.В., Лоскутова А.С., Рябыкина Г.В., Архипова О.А. и др. Сопоставление векторкардиографических параметров со структурно-функциональным состоянием правого желудочка у пациентов с легочной гипертензией. Системные гипертензии. 2015; 12 (4): 57–60.
  34. Белевская А.А., Дадачева З.Х., Саидова М.А., Мартынюк Т.В., Чазова И.Е. Возможности эхокардиографии в диагностике легочной гипертензии и оценке ремоделирования сердца. Лечебное дело. 2015; 1: 111– 21.
  35. Валиева З.С., Грацианская С.Е., Мартынюк Т.В. Применение риоцигуата для лечения пациентов с хронической тромбоэмболической легочной гипертензией. Кардиология. 2020; 60 (8): 115–23. DOI: 10.18087/cardio.2020.8.n1198
  36. Чазова И.Е. Хроническая тромбоэмболическая легочная гипертензия: современные возможности диагностики и лечения. Терапевтический архив. 2023; 95 (12): 1017–21. DOI: 10.26442/00403660.2023.12.202495
  37. Snyder W., Kent D., Baisch B. Successful endarterectomy of chronically occluded pulmonary artery: clinical report and physiologic studies. J. Thorac. Cardiovasc. Surg. 1964; 45: 482–9.
  38. Jamieson S.W. Historical perspective: surgery for chronic thromboembolic disease. Semin. Thorac. Cardiovasc. Surg. 2006; 18: 218–22. DOI: 10.1053/j.semtcvs.2006.09.007
  39. Jamieson S.W., Kapelanski D.P., Sakakibara N., Manecke G.R., Thistlethwaite P.A., Kim M.K. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann. Thorac. Surg. 2003; 76 (5): 1457–64. DOI: 10.1016/s0003-4975(03)00828-2
  40. Чазова И.Е., Мартынюк Т.В. (ред.) Легочная гипертензия. М.: Практика; 2015: 563–93.
  41. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009; 119 (16): 2250–94. DOI: 10.1161/CIRCULATIONAHA.109.192230
  42. Eckhard M., Walter K., Mayer E., Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc. Am. Thorac. Soc. 2006; 3 (7): 589–93. DOI: 10.1513/pats.200605-120LR
  43. Jenkins D., Madani M., Fadel E., D'Armini A.M., Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur. Resp. Rev. 2017; 26: 160111. DOI: 10.1183/16000617.0111-2016
  44. Kim N.H., Delcroix M., Jenkins D.P., Channick R., Dartevelle P., Jansa P. et al. Chronic thromboembolic pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62: 92–9. DOI: 10.1016/j.jacc.2013.10.024
  45. D'Armini A.M., Morsolini M., Mattiucci G., Grazioli V., Pin M., Valentini A. et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 2014; 148: 1005–11; 1012.e1–e2; discussion 1011–2. DOI: 10.1016/j.jtcvs.2014.06.052
  46. Pepke-Zaba J., Delcroix M., Lang I., Mayer E., Jansa P., Ambroz D. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011; 124: 1973–81. DOI: 10.1161/CIRCULATIONAHA.110.015008
  47. Freed D.H., Thomson B.M., Berman M., John D., Karen K.Sh., Pepke-Zaba J. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 2011; 141: 383–7. DOI: 10.1016/j.jtcvs.2009.12.056
  48. Mizoguchi H., Ogawa A., Munemasa M., Mikouchi H., Ito H., Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv. 2012; 5: 748–55. DOI: 10.1161/CIRCINTERVENTIONS.112.971077
  49. Sugimura K., Fukumoto Y., Satoh K., Nochioka K., Miura Y., Aoki T. et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ. J. 2012; 76: 485–8. DOI: 10.1253/circj.cj-11-1217
  50. Kataoka M., Inami T., Hayashida K., Shimura N., Ishiguro H., Abe T. et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv. 2012; 5: 756–62. DOI: 10.1161/CIRCINTERVENTIONS.112.971390
  51. Чернявский М.А., Аляпкина Е.М., Мироненко А.А., Альсов С.П., Карпенко А.М., Чернявский А.М. Динамика качества жизни у больных с хронической постэмболической легочной гипертензией после операции тромбэндартерэктомии из ветвей легочной артерии. Патология кровообращения и кардиохирургия. 2010; 4: 56–60.
  52. Mayer E., Jenkins D., Lindner J., D'Armini A., Kloek J., Meyns B. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J. Thorac. Cardiovasc. Surg. 2011; 141: 702–10. DOI: 10.1016/j.jtcvs.2010.11.024
  53. Nierlich P., Hold A., Ristl R. Outcome after surgical treatment of chronic thromboembolic pulmonary hypertension: dealing with different patient subsets. A single-centre experience. Eur. J. Cardiothorac. Surg. 2016; 50: 898– 906. DOI: 10.1093/ejcts/ezw099
  54. Hoeper M.M., Madani M., Nakanishi N., Meyer B., Cebotari S., Rubin L.J. et al. Chronic thromboembolic pulmonary hypertension. Lancet Respir. Med. 2014; 2: 573–82. DOI: 10.1016/S2213-2600(14)70089-X
  55. Vuylsteke A., Sharples L., Charman G., Kneeshaw J., Tsui S., Dunning J. et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomized controlled trial. Lancet. 2011; 378: 1379–87. DOI: 10.1016/S0140-6736(11)61144-6
  56. Цыренов Д.Д., Акчурин Р.С., Мершин К.В., Табакьян Е.А., Власова Э.Е., Газизов В.В. и др. Кардиологические аспекты периоперационного ведения больных хронической тромбоэмболической легочной гипертензией при тромбэндартерэктомии из ветвей легочной артерии. Евразийский кардиологический журнал. 2021; 1: 94–104. DOI: 10.38109/2225-1685-2020-3-94-104
****
  1. Chazova I.E., Martynyuk T.V. Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2). Therapeutic Archive. 2016; 88 (10): 63–73 (in Russ.). DOI: 10.17116/terarkh201688663-73
  2. Chazova I.E., Martynyuk T.V., Valieva Z.S., Azizov V.A., Akchurin R.S., Ansheles A.A. et al. Eurasian Association of Cardiology (EAC) guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (2020). Eurasian Heart Journal. 2021; 1: 6–43 (in Russ.). DOI: 10.38109/2225-1685-2021-1-6-43
  3. Galie N., Humbert M., Vachiery J.L., Simon G., Irene L., Adam T. et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension 2015. The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Heart J. 2016; 37: 67–119. DOI: 10.1093/eurheartj/ehv317
  4. Valieva Z.S., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E. Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry. Therapeutic Archive. 2021; 93 (9): 1058–65 (in Russ.). DOI: 10.26442/00403660.2021.09.201037
  5. Hoeper M.M., Humbert M., Souza R., Idrees M., Steven M.K., Karen S.H. et al. A global view of pulmonary hypertension. Lancet Respir. Med. 2016; 4: 306–22. DOI: 10.1016/S2213-2600(15)00543-3
  6. Lang I.M., Dorfmüller P., Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann. Am. Thorac Soc. 2016; 13 (Suppl. 3): 215–21. DOI: 10.1513/AnnalsATS.201509-620AS
  7. Wartski M., Collignon M.A. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou heparin standard: evaluation dans l'embolie pulmonaire study. J. Nucl. Med. 2000; 41: 1043–8.
  8. Klok F.A., van Kralingen K.W., van Dijk A.P., Fenna H.H., Hubert W.V., Menno V.H. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010; 95: 970–5. DOI: 10.3324/haematol.2009.018960
  9. Pengo V., Lensing W.A., Prins M.H., Marchiori A., Davidson B.L. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N. Engl. J. Med. 2004; 350: 2257–64. DOI: 10.1056/NEJMoa032274
  10. Guérin L., Couturaud F., Parent F., Revel M.P., Gillaizeau F., Planquette B. et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb. Haemost. 2014; 112: 598–605. DOI: 10.1160/TH13-07-0538
  11. Simonneau G., Hoeper M.M. Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2017; 49 (2): 1602522. DOI: 10.1183/13993003.02522-2016
  12. Gall H., Hoeper M.M., Richter M.J., Cacheris W., Hinzmann B., Mayer E. et al. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur. Respir. Rev. 2017; 26: 160121. DOI: 10.1183/16000617.0121-2016
  13. Simonneau G., Torbicki A., Dorfmüller P., Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017; 26: 160112. DOI: 10.1183/16000617.0112-2016
  14. Madani M.M., Auger W.R., Pretorius V., Sakakibara N., Kerr K.M., Kim N.H. et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann. Thorac. Surg. 2012; 94 (1): 97–103. DOI: 10.1016/j.athoracsur.2012.04.004
  15. Mershin K.V., Akchurin R.S. Chronic thromboembolic pulmonary hypertension. In: Chazova I.E., Martynyuk T.V. (Eds). Pulmonary hypertension. Moscow; 2015: 563–606 (in Russ.).
  16. Bonderman D., Wilkens H., Wakounig S., Schäfers H.J., Jansa P., Lindner J. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33: 325–31. DOI: 10.1183/09031936.00087608
  17. Suntharalingam J., Goldsmith K., van Marion V., Long L., Treacy C.M., Dudbridge F. et al. Fibrinogen AThr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2008; 31: 736-41. DOI: 10.1183/09031936.00055107
  18. Marsh J.J. Chiles P.G., Liang Ni-Cheng, Morris T.A. Chronic thromboembolic pulmonary hypertensionassociated dysfibrinogenemias exhibit disorganized fibrin structure. Thromb. Res. 2013; 132: 729–34. DOI: 10.1016/j.thromres.2013.09.024
  19. Morris T.A., Marsh J.J., Chiles P.G., Auger W.R., Fedullo P.F., Woods V.L. et al. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am. J. Respir. Crit. Care Med. 2006; 173: 1270–5. DOI: 10.1164/rccm.200506-916OC
  20. Chernyavsky A.M., Edemsky A.G., Chernyavsky M.A., Karaskov A.M. Chronic thromboembolic pulmonary hypertension. In: Avdeev S.N. (Ed.) Pulmonary hypertension. 2nd edition. Moscow; 2019: 365–418 (in Russ.).
  21. Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 2001; 345: 1465–72. DOI: 10.1056/NEJMra010902
  22. Chazova I.E., Martynyuk T.V. Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1). Therapeutic Archive. 2016; 88 (9): 90–101 (in Russ.). DOI: 10.17116/terarch201688990-101
  23. Delcroix M., Lang I., Pepke-Zaba J., Jansa P., D'Armini A.M., Snijder R. et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation. 2016; 133: 859-71. DOI: 10.1161/CIRCULATIONAHA.115.016522
  24. Kim N.H., Delcroix M., Jais X., Madani M.M., Matsubara H., Mayeret E. et al. Chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019; 53: 1801915. DOI: 10.1183/13993003.01915-2018
  25. Saveliev V.S., Yablokov E.G., Kirienko A.I. Pulmonary embolism. Moscow; 1979: 264 (in Russ.).
  26. Wagenvoort С.A. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest. 1980; 77: 614–25. DOI: 10.1378/chest.77.5.614
  27. Matyushenko A.A. Chronic postembolic pulmonary hypertension. In: Saveliev V.S. (Ed.) 50 lectures on surgery. Moscow; 2003: 99–105 (in Russ.).
  28. Rich S., Levitsky S., Brundage В.Н. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann. Intern. Med. 1988; 108 (5): 425–54. DOI: 10.7326/0003-4819-108-3-425
  29. Kelly S., Zongye C., van der Velde N., van Duin R., Lam E., van der Velden J. et al. Cardiac remodelling in a swine model of chronicthromboembolic pulmonary hypertension: comparison of right vs. left ventricle. J. Physiol. 2019; 597 (17): 4465–80. DOI: 10.1113/JP277896
  30. Grifoni S., Olivotto I., Cecheini P., Pieralli F., Camaiti A., Santoro G. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101: 2817–22. DOI: 10.1161/01.cir.101.24.2817
  31. Banks D.A., Pretorius G.V., Kerr K.M., Manecke G.R. Pulmonary endarterectomy: Part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin. Cardiothorac. Vasc. Anesth. 2014; 18 (4): 319–30. DOI: 10.1177/1089253214536621
  32. Korsholm K., Andersen A., Mellemkjаеr S., Niclsen D.V., Klaaborg K.E. et al. Results from more than 20-years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark. Eur. J. Cardiothorac. Surg. 2017; 52 (4): 704–9. DOI: 10.1093/ejcts/ezx182
  33. Blinova E.V., Sakhnova T.A., Martynyuk T.V., Loskutova A.S., Ryabykina G.V., Arkhipova O.A. et al. Comparison of vectorcardiographic parameters with the structural and functional state of the right ventricle in patients with pulmonary hypertension. Systemic Hypertension. 2015; 12 (4): 57–60 (in Russ.).
  34. Belevskaya A.A., Dadacheva Z.Kh., Saidova M.A., Martynyuk T.V., Chazova I.E. Possibilities of echocardiography in the diagnosis of pulmonary hypertension and assessment of cardiac remodeling. Medical Business. 2015; 1: 111–21 (in Russ.).
  35. Валиева З.С., Грацианская С.Е., Мартынюк Т.В. Применение риоцигуата для лечения пациентов с хронической тромбоэмболической легочной гипертензией. Кардиология. 2020; 60 (8): 115–23. DOI: 10.18087/cardio.2020.8.n1198
  36. Chazova I.E. Chronic thromboembolic pulmonary hypertension: modern possibilities of diagnosis and treatment. Therapeutic Archive. 2023; 95 (12): 1017–21 (in Russ.). DOI: 10.26442/00403660.2023.12.202495
  37. Trendelenburg. Uberdie operativ ebehand lung derembo lieder lung arterie. Arch. Klin. Chir. 1908; 86: 686–700.
  38. Snyder W., Kent D., Baisch B. Successful endarterectomy of chronically occluded pulmonary artery: clinical report and physiologic studies. J. Thorac. Cardiovasc. Surg. 1964; 45: 482–9.
  39. Jamieson S.W. Historical perspective: surgery for chronic thromboembolic disease. Semin. Thorac. Cardiovasc. Surg. 2006; 18: 218–22. DOI: 10.1053/j.semtcvs.2006.09.007
  40. Jamieson S.W., Kapelanski D.P., Sakakibara N., Manecke G.R., Thistlethwaite P.A., Kim M.K. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann. Thorac. Surg. 2003; 76 (5): 1457–64. DOI: 10.1016/s0003-4975(03)00828-2
  41. Chazova I.E., Martynyuk T.V. Pulmonary hypertension. Moscow; 2015: 563–93 (in Russ.).
  42. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009; 119 (16): 2250–94. DOI: 10.1161/CIRCULATIONAHA.109.192230
  43. Eckhard M., Walter K., Mayer E., Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc. Am. Thorac. Soc. 2006; 3 (7): 589–93. DOI: 10.1513/pats.200605-120LR
  44. Jenkins D., Madani M., Fadel E., D'Armini A.M., Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur. Resp. Rev. 2017; 26: 160111. DOI: 10.1183/16000617.0111-2016
  45. Kim N.H., Delcroix M., Jenkins D.P., Channick R., Dartevelle P., Jansa P. et al. Chronic thromboembolic pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62: 92–9. DOI: 10.1016/j.jacc.2013.10.024
  46. D'Armini A.M., Morsolini M., Mattiucci G., Grazioli V., Pin M., Valentini A. et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 2014; 148: 1005–11; 1012.e1–e2; discussion 1011–2. DOI: 10.1016/j.jtcvs.2014.06.052
  47. Pepke-Zaba J., Delcroix M., Lang I., Mayer E., Jansa P., Ambroz D. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011; 124: 1973–81. DOI: 10.1161/CIRCULATIONAHA.110.015008
  48. Freed D.H., Thomson B.M., Berman M., John D., Karen K.Sh., Pepke-Zaba J. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 2011; 141: 383–7. DOI: 10.1016/j.jtcvs.2009.12.056
  49. Mizoguchi H., Ogawa A., Munemasa M., Mikouchi H., Ito H., Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv. 2012; 5: 748–55. DOI: 10.1161/CIRCINTERVENTIONS.112.971077
  50. Sugimura K., Fukumoto Y., Satoh K., Nochioka K., Miura Y., Aoki T. et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ. J. 2012; 76: 485–8. DOI: 10.1253/circj.cj-11-1217
  51. Kataoka M., Inami T., Hayashida K., Shimura N., Ishiguro H., Abe T. et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv. 2012; 5: 756–62. DOI: 10.1161/CIRCINTERVENTIONS.112.971390
  52. Chernyavsky M.A., Alyapkina E.M., Mironenko A.A., Alsov S.P., Karpenko A.M., Chernyavsky A.M. Dynamics of quality of life in patients with chronic postembolic pulmonary hypertension after thrombendarterectomy from branches of the pulmonary artery. Circulation Pathology and Cardiac Surgery. 2010; 4: 56–60 (in Russ.).
  53. Mayer E., Jenkins D., Lindner J., D'Armini A., Kloek J., Meyns B. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J. Thorac. Cardiovasc. Surg. 2011; 141: 702–10. DOI: 10.1016/j.jtcvs.2010.11.024
  54. Nierlich P., Hold A., Ristl R. Outcome after surgical treatment of chronic thromboembolic pulmonary hypertension: dealing with different patient subsets. A single-centre experience. Eur. J. Cardiothorac. Surg. 2016; 50: 898– 906. DOI: 10.1093/ejcts/ezw099
  55. Hoeper M.M., Madani M., Nakanishi N., Meyer B., Cebotari S., Rubin L.J. et al. Chronic thromboembolic pulmonary hypertension. Lancet Respir. Med. 2014; 2: 573–82. DOI: 10.1016/S2213-2600(14)70089-X
  56. Vuylsteke A., Sharples L., Charman G., Kneeshaw J., Tsui S., Dunning J. et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomized controlled trial. Lancet. 2011; 378: 1379–87. DOI: 10.1016/S0140-6736(11)61144-6
  57. Tsyrenov D.D., Akchurin R.S., Mershin K.V., Tabakyan E.A., Vlasova E.E., Gazizov V.V. et al. Cardiological aspects of perioperative management of patients with chronic thromboembolic pulmonary hypertension during thrombendarterectomy from branches of the pulmonary artery. Eurasian Heart Journal. 2021; 1: 94–104 (in Russ.). DOI: 10.38109/2225-1685-2020-3-94-104

About Authors

  • Amirullo A. Sabitov, Cardiovascular Surgeon; ORCID
  • Igor E. Chernogrivov, Dr. Med. Sci., Head of Department of Surgical Treatment of Heart Diseases with Progressive Pulmonary Hypertension; ORCID
  • Anton A. Shmalts, Dr. Med. Sci., Leading Researcher, Associate Professor of Chair of Cardiovascular Surgery; ORCID
  • Sergey V. Gorbachevsky, Dr. Med. Sci., Professor, Chief Researcher; ORCID

 If you found mistakes, select text and press Alt+A